Aguirre-Ghiso Lab
@jaguirreghisolab.bsky.social
510 followers 740 following 130 posts
We study how micro-environmental and epigenetic mechanisms drive cancer cells into dormancy. We seek to control this biology to prevent and treat metastasis. https://einsteinmed.edu/faculty/16974/julio-aguirre-ghiso
Posts Media Videos Starter Packs
Reposted by Aguirre-Ghiso Lab
soledadsosalab.bsky.social
@susangkomen.bsky.social It is a profound honor to accept the Susan G. Komen Next Generation Researcher Award. Thanks for making me feel part of
this community and our shared fight against cancer. Thanks to my lab members, my family and my husband for making this possible. @cdi-einstein.bsky.social
jaguirreghisolab.bsky.social
So proud of you !! A hugely deserved recognition of your past work and future vision. Congratulations!!
jaguirreghisolab.bsky.social
On Tuesday I had a great day of science and discussions visiting @danafarber.bsky.social & delivering the Harriet Tischler Memorial Lecture - thanks again Kornelia Polyak for a great day & for the stellar company during dinner with the amazing Joan Brugge and Alex Toker. @cdi-einstein.bsky.social
jaguirreghisolab.bsky.social
Super honored to be visiting @danafarber.bsky.social to deliver the 2025 Harriet Tischler Memorial Lecture hosted by the amazing Nelly Polyak. Thanks for the invitation!
seminarsinoncology.dana-farber.org
jaguirreghisolab.bsky.social
Great @cdi-einstein.bsky.social seminar by Jose Javier Bravo Cordero from @mountsinainyc.bsky.social covering ECM architecture, metabolism and neuroscience. Fantastic work! Thanks for visiting us!
jaguirreghisolab.bsky.social
But acting early is key. Managing late-stage metastatic symptoms is necessary but will likely offer only marginal survival gains. Treatments moved from stage IV to the adjuvant phase have revolutionized outcomes (Trastuzumab, Pembrolizumab, Osimertinib & combinations like Dabrafenib & Trametinib)
jaguirreghisolab.bsky.social
These data lead to the question, what do we need to focus on to change survival? Targeting metastasis early before they start to cause all the problems mentioned above or intervene the actual consequences of metastasis. Maybe both?
jaguirreghisolab.bsky.social
Are 90% of cancer-related deaths due to metastasis? Apparently the overuse of this percentage in reviews has created confusion and questioning of whether this is true. The answer, which is as always cancer type dependent, may be in these references that also people claim they cannot find.
jaguirreghisolab.bsky.social
Delighted to host Dr. Javier Bravo Cordero at our Cancer Dormancy Institute Seminar Series. Don't miss his exceptional work! @cdi-einstein.bsky.social @einsteinmededu.bsky.social @einsteincellbio.bsky.social
jaguirreghisolab.bsky.social
I could not stay the entire meeting but it was great seeing friends and colleagues Evi Lianidou, Angela Nieto AndreasTrumpp Caroline Dive and many more at the 7th ACTC Meeting in Thessaloniki, Greece. Great to bring the science we are developing @cdi-einstein.bsky.social to this meeting.
jaguirreghisolab.bsky.social
Delighted to have opened this fantastic meeting in beautiful Thessaloniki organized by the equally amazing Evi Lianidou presenting updates from the lab @cdi-einstein.bsky.social including our CH collaborative work with @rosslevinemd.bsky.social lab.

www.erasmus.gr/microsites/1...
jaguirreghisolab.bsky.social
Excited about a day of exceptional cancer science being developed at our @einsteinmededu.bsky.social comprehensive cancer center. Featuring science being developed at our Cancer Dormancy Institute @cdi-einstein.bsky.social - proud to be part of this amazing community
jaguirreghisolab.bsky.social
Happy to give the fist talk at this amazing symposium on our work with @rosslevinemd.bsky.social - thanks to @themarkfdn.bsky.social and the Samuel Waxman Cancer Research Foundation for their support ! Thanks to @jacksonlab.bsky.social for hosting and teaming on this symposium.
jaguirreghisolab.bsky.social
Wonderful afternoon of games and good food with the lab last week celebrating our strong team.